Sequence of therapy impact on older women with comorbidities and triple-negative or HER2-positive breast cancer

Sequence of therapy impact on older women with comorbidities and triple-negative or HER2-positive breast cancer

Abstract We sought to determine whether sequencing of treatment impacted outcomes in older, comorbid patients. Using the National Cancer Database(2010–2017), 2911 patients >70 with a Charleson Deyo Comorbidity(CCDM) score of 2/3 and cT1c-3/N0-3/HER2 positive or triple-negative breast cancer treat...

Full description

Saved in:
Bibliographic Details
Main Authors: Nina Tamirisa, Wenli Dong, Yu Shen, Heather Lin, Simona F. Shaitelman, Gildy Babiera, Isabelle Bedrosian
Format: Article
Language:English
Published: Nature Portfolio 2025-02-01
Series:npj Breast Cancer
Online Access:https://doi.org/10.1038/s41523-025-00732-z
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41523-025-00732-z

Similar Items